Standout Papers

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma 2007 2026 2013 2019 2.8k
  1. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma (2007)
    Gary R. Hudes, Michael A. Carducci et al. New England Journal of Medicine

Immediate Impact

5 by Nobel laureates 30 from Science/Nature 81 standout
Sub-graph 1 of 20

Citing Papers

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
2022 Standout
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
2021 StandoutNature
20 intermediate papers

Works of David McDermott being referenced

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout

Author Peers

Author Last Decade Papers Cites
David McDermott 2313 2184 297 1269 3 3.1k
Vladimir Lesovoy 2294 2178 259 1295 8 3.4k
Janice Dutcher 2516 2351 269 1363 13 3.6k
Jordan Rossen 1181 1665 148 1104 5 3.4k
Gladys Urbanowitz 2175 1904 563 981 12 4.1k
Debasish Roychowdhury 2053 1453 278 858 19 3.0k
Teresa A. Goldin 1193 2060 729 1263 5 4.7k
Juan José Zarbá 1972 1527 375 954 13 2.9k
Mustafa Kocak 1172 1582 140 1057 7 3.3k
Sai Akshaya Hodigere Balasubramanya 1756 3364 210 1661 8 4.5k
Timothy Eisen 1910 1803 367 999 17 3.5k

All Works

Loading papers...

Rankless by CCL
2026